Threats and Reimbursement Issues to the 340B Drug Discount Program (On-Demand Webinar)
Threats and Reimbursement Issues to the 340B Drug Discount Program
Time: 2:00-3:30 PM ET
Overview: Join us to discuss the recent developments surrounding the 340B Drug Discount Program. The conversation will range from manufacturer and PBM threats to covered entities and their contract pharmacies, to legislative and policy updates. Hear from Trent Stechschulte, General Counsel & Compliance Officer, for a covered entity that manages these threats internally. Jason Reddish, a partner at Feldesman Tucker Lifer & Fidell, and Kyle Vasquez, a shareholder at Polsinelli, who focuses their practice on the federal 340B Drug Discount Program and the complex legal and compliance issues facing safety net providers and pharmacies.
This webinar is brought to you by the Regulation, Accreditation and Payment Practice Group.
On-Demand Webinars are not included in AHLA Premium or other
AHLA is now offering Continuing Education Credit for On-Demand Webinars held after March 2021. This is a 90-minute webinar. Credits earned for a 50 minute state are 1.8 CLEs, and 1.5 CLEs for a 50 minute state.